Investors.renalytix.com

  1. Home
  2. Investors.renalytix.com

US Government coverage expanded Renalytix

WEBRenalytix plc. ("Renalytix" or the "Company") Renalytix Expands US Government Coverage for FDA Approved kidneyintelX.dkd Testing at $950. Data to be …

Actived: 8 days ago

URL: https://investors.renalytix.com/news-releases/news-release-details/us-government-coverage-expanded

Positive Study Results Published for KidneyIntelX™ in

WEBAmerican Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin …

Category:  Health Go Health

Renalytix Announces Two Data Presentations on KidneyIntelX™ at …

WEBReal-world clinical utility in 1,112 patients tested with KidneyIntelX KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney disease …

Category:  Health Go Health

New published data for KidneyIntelX™ Renalytix

WEBAbout Chronic Kidney Disease. Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally. The Centers for …

Category:  Health Go Health

FDA grants Breakthrough Device designation to KidneyIntelX™

WEBTel: 020 7933 8780. [email protected]. Paul McManus. Lianne Cawthorne. Mob: 07980 541 893. 07584 391 303. About Kidney Disease. Kidney …

Category:  Health Go Health

Published Real World Evidence Demonstrates KidneyIntelX

WEBRisk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an …

Category:  Health Go Health

KidneyIntelX evidence presented at ADA Renalytix

WEBAbout Chronic Kidney Disease. Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally. The Centers for Disease …

Category:  Health Go Health

St. Joseph’s Health and Renalytix Partner to Advance Value-Based …

WEBPartnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease. NEW YORK, Nov. …

Category:  Health Go Health

Data Supportive of KidneyIntelX Utility in Minorities and

WEBIn a clinical decision effectiveness study, KidneyIntelX classified more Black vs non-Black patients as high risk for progression of chronic kidney disease, resulting in …

Category:  Health Go Health

Joint program with American Diabetes Association Renalytix

WEBRenalytix plc ("Renalytix" or the "Company") American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population. …

Category:  Health Go Health

Real-World Evidence Shows KidneyIntelX™ Utility Renalytix

WEBAbout Kidney Disease. Kidney disease is a public health epidemic affecting over 850 million people globally. 1 The Centers for Disease Control and Prevention …

Category:  Health Go Health

Mount Sinai Initiates System-wide Scale-Up of Renalytix …

WEBTargeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021. NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE …

Category:  Health Go Health

Renalytix Launches myIntelX Renalytix

WEBRenalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform. myIntelX will be launching in conjunction with …

Category:  Health Go Health

Utility Study Renalytix

WEBAbout Kidney Disease. Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally. The Centers for Disease Control and …

Category:  Health Go Health

Clinical utility study data: further highlights Renalytix

WEBAbout Kidney Disease. Kidney disease is a public health epidemic affecting over 850 million people globally. 1 The Centers for Disease Control and Prevention …

Category:  Health Go Health

Renalytix Reaches Enrollment Milestone for Building KidneyIntelX …

WEBKidneyIntelX RAPID biobank program and partners on track to reach over 30,000 biospecimens with matched electronic health records from multiple centers …

Category:  Health Go Health

Renalytix Completes Agreement with Veterans Administration to …

WEBSignificant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease. LONDON and SALT LAKE CITY, Jan. 09, 2023 (GLOBE …

Category:  Health Go Health

FDA Approves KidneyIntelX.dkd™ Renalytix

WEBFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage …

Category:  Health Go Health

CMS publishes Draft Local Coverage Determination Renalytix

WEBTel: 415-389-6400 or [email protected]. About Renalytix. Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › 1 life health care buyout

 › Community health grafton nd

 › Oregon behavioral health news

 › Dearborn mi health department

 › Change health care neil de

 › Yas mental health hull

 › Home health care rental equipment

 › Simple health care log in

 › Fatty liver diet healthline

 › Health department fort worth texas

Recently Searched

 › Quality of health care ethics

 › Lotus health hardeeville sc

 › Yas mental health team

 › Health benefits of ginisang munggo

 › Global pediatric health articles

 › Supplemental health care union park

 › Mental health ambulance hull

 › Interim home health care reviews

 › Quest for health care professionals

 › How dust affects human health